Navigation Links
Silence Therapeutics Provides Corporate and Development Update
Date:11/8/2011

LONDON, November 8, 2011 /PRNewswire/ --

Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), a leading RNA interference (RNAi) therapeutics company, today provides an update on recent business and clinical developments.

Expansion of business development team

Silence today announces the appointment of Dr Georg Buchner as VP Business Development. Georg will work with Tony Sedgwick who was appointed as Silence's Chief Business Officer in September as part of the Company's strategy to continue to broaden its collaborations with global pharmaceutical and biotechnology companies. Georg was formerly VP of Corporate & Business Development at Novacta Biosystems Ltd. Prior to joining Novacta, Georg was Business Development Director at Haptogen Ltd and was instrumental in the sale of the business to Wyeth (now part of Pfizer) in 2007. Georg gained a PhD in Molecular Genetics from King's College London and an MBA from The University of Cambridge's Judge Institute of Management.

Atu027 trial update

Results from the ongoing Phase I trial of Atu027, Silence's lead siRNA development programme for the treatment of advanced solid cancer, now confirm that 10 out of 27 (37%) patients treated to date have shown stable disease after the treatment phase of the trial. Dosing of the first patient in cohort 10 of the 11 cohort trial has now commenced and the trial is on track to complete recruitment in early 2012 with results reported by mid-2012.  Atu027 incorporates AtuPLEX™, Silence's proprietary delivery technology that transports RNAi molecules to the target site with high specificity.

Atu134 development update

Following further encouraging data generate
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. National Ovarian Cancer Coalition and PureOlogy to Host First Annual NOCC and PureOlogys Walk to Break the Silence on Ovarian Cancer
2. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
3. Silence Therapeutics Appoints New Vice President of Research
4. Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States
5. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
6. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
7. Silence Therapeutics Receives Comprehensive Protection for RNAi Structural Modification Technology in Single European Patent
8. Silence Therapeutics Lead RNA Interference Therapeutic Prevents Spread of Cancer to Lungs
9. Silence Therapeutics Issued Japanese Patent Covering its Core RNA Interference (RNAi) Technology
10. Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics
11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... PRC Clinical, a full-service, ... Bay Area, will exhibit and present at the ... on March 25th and 26th in Tel Aviv, Israel. ... Israeli life science companies seeking to conduct U.S. Food ... span all phases of human trials, from Phase I ...
(Date:3/4/2015)... 4, 2015 Vegalab announced the acquisition of ... last year. As part of the acquisition, Ecowin rebranded ... continuing his role as CEO for the company,s Korea ... will work alongside Koo and oversee developments at the ... Koo founded Ecowin in 2008 ...
(Date:3/4/2015)... Massachusetts , March 4, 2015 ... präsentiert innovative Entwicklungen für Diagnostik und Therapie, Strahlendosismanagement ...   Royal Philips (NYSE: ... Europäischen Röntgenkongress 2015 (ECR) bekannt, der ... stattfindet. An den Ständen Nr. 102 ...
(Date:3/3/2015)... Experts and industry insiders from around the ... Alltech REBELation exploring innovation, inspiration and world-changing ideas in ... 31st year, Alltech’s annual international conference traditionally draws more ... to join the REBELation at an extra discount registration ... at which point the standard early registration rate will ...
Breaking Biology Technology:PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... Montgomery County Facility To Create At Least 260 ... ,Governor Edward G. Rendell helped to break ground ... Almac Group, a Northern Ireland-based provider,of research, development ... Last October, Governor Rendell announced a state ...
... - Company Will Request Hearing to Present Plans for Regaining Compliance ... Peregrine Up to an ... Regain Compliance -,- Peregrine Currently Meets All Other NASDAQ Capital Market ... the $1.00 Minimum Bid Price Rule -, TUSTIN, Calif., July ...
... Genome,Sciences, Inc. (Nasdaq: HGSI ) today announced that ... results for the quarter ended June,30, 2008. These results ... after the capital markets close., (Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ... by senior management and will be,held on Wednesday, July ...
Cached Biology Technology:Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Company's North American Headquarters 2Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Company's North American Headquarters 3Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 2Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 3Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 4Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results 2
(Date:2/5/2015)... Conn. , Jan. 28, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... at the upcoming RedChip Global Online CEO Conference on ... Gino Pereira , CEO of NXT-ID ... its lead product, the Wocket smart wallet and its ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
(Date:1/22/2015)... 2015 Technology Showcase, Hall E -   EyeLock Inc. ... announced it will showcase its EyeLock ID technology integrated in ... of Energy,s Oak Ridge National Laboratory (ORNL) at ... iris identity authentication technology is being used to validate the ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... VANCOUVER, British Columbia -- Ecologists have long believed that ... hatched in order to spawn. But researchers at Ohio State ... -- not for Lake Erie walleye, at least. Using ... the researchers were able to calculate the percentage of walleye ...
... that will be published online on the 28th of ... team of scientists mapped and analyzed global biodiversity patterns ... to sharks and whales. The researchers found striking similarities ... biodiversity for all thirteen groups studied. These results imply ...
... medication, first isolated from the saliva of sea snails, that ... severe forms of pain as effectively as morphine but without ... current issue of Chemical & Engineering News (C&EN), ACS, weekly ... a sea snails, saliva contains chemicals that help the slow-moving ...
Cached Biology News:Ear bones reveal spawning secrets of Lake Erie walleye 2Ear bones reveal spawning secrets of Lake Erie walleye 3Ear bones reveal spawning secrets of Lake Erie walleye 4Scientists uncover global distribution of marine biodiversity 2Scientists uncover global distribution of marine biodiversity 3
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
UV LAMP 254 NM 8 WATT, 1 EA. Category: Nucleid Acid Detection Systems....
... SelectFX Alexa Fluor 488 Cytochrome c Apoptosis ... need to detect cytochrome c in fixed ... primary antibody and an Alexa Fluor ... dye exhibits bright green fluorescence that is ...
Biology Products: